Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 45 Records) |
Query Trace: Myelodysplastic Syndromes and DNMT3A[original query] |
---|
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing. Oncotarget 2017 Oct 8 (47): 82475-82490. Xu Yuanyuan, Li Yan, Xu Qingyu, Chen Yuelong, Lv Na, Jing Yu, Dou Liping, Bo Jian, Hou Guangyuan, Guo Jing, Wang Xiuli, Wang Lili, Li Yonghui, Chen Chongjian, Yu |
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine. Oncotarget 2018 Apr 9 (27): 19342-19355. Cabezón Marta, Bargay Joan, Xicoy Blanca, García Olga, Borrás Josep, Tormo Mar, Marcé Sílvia, Pedro Carme, Valcárcel David, Jiménez Maria-José, Guàrdia Ramón, Palomo Laura, Brunet Salut, Vall-Llovera Ferran, Garcia Antoni, Feliu Evarist, Zamora Lurdes, |
Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of cancer research and clinical oncology 2018 Mar . Lin Peipei, Luo Yingwan, Zhu Shuanghong, Maggio Dominic, Yang Haiyang, Hu Chao, Wang Jinghan, Zhang Hua, Ren Yanling, Zhou Xinping, Mei Chen, Ma Liya, Xu Weilai, Ye Li, Zhuang Zhengping, Jin Jie, Tong Hongy |
Prognostic value of DNMT3A mutations in myelodysplastic syndromes: a meta-analysis. Hematology (Amsterdam, Netherlands) 2019 9 24 (1): 613-622. Liang Simin, Zhou Xiaojia, Pan Hui, Yang Yichun, Shi Lin, Wang |
[Mutation analysis of 77 patients with normal-karyotype myelodysplastic syndrome]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Sep 36 (9): 857-861. Qin Wei, Chen Meiyu, Cai Xiaohui, Chao Hongying, Liu Jie, Jiang Naike, Zhou Min, Lu Xuzhang, Chen Suning, Zhang Ri, He Chuan, Wang Qi |
Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome. Cancer 2019 3 125 (13): 2233-2241. Naqvi Kiran, Sasaki Koji, Montalban-Bravo Guillermo, Alfonso Pierola Ana, Yilmaz Musa, Short Nicholas, Assi Rita, Jabbour Elias, Ravandi Farhad, Kadia Tapan, Pierce Sherry, Takahashi Koichi, Nogueras Gonzalez Graciela, Kanagal-Shamanna Rashmi, Patel Keyur, Soltysiak Kelly A, Kantarjian Hagop M, Garcia-Manero Guiller |
Combining gene variants with clinical characteristics improves outcome prediction in Chinese patients with myelodysplastic syndromes. Leukemia & lymphoma 2019 Dec 1-8. Yu Yan, Zhang Tongtong, Bao Xiebing, Wang Qinrong, Zhang Ling, Hong Yang, Zeng Zhao, Shen Hongjie, Wu Depei, Pan Jinlan, Liu Hong, Chen Suning, Sun Aini |
Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome. Journal of clinical pathology 2019 11 73 (4): 209-212. Badaat Ibraahim, Mirza Sabbir, Padron Eric, Sallman David, Komrokji Rami, Song Jinming, Hussaini Mohammad |
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood advances 2019 Oct 3 (20): 3111-3122. Berger Gerbrig, Gerritsen Mylene, Yi Guoqiang, Koorenhof-Scheele Theresia N, Kroeze Leonie I, Stevens-Kroef Marian, Yoshida Kenichi, Shiraishi Yuichi, van den Berg Eva, Schepers Hein, Huls Geert, Mulder André B, Ogawa Seishi, Martens Joost H A, Jansen Joop H, Vellenga E |
Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology (Amsterdam, Netherlands) 2020 6 25 (1): 211-218. Wang Kai, Zhou Feng, Cai Xiaohui, Chao Hongying, Zhang Ri, Chen Suni |
[Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis. Haematologica 2021 9 107 (8): 1815-1826. Gutierrez-Rodrigues Fernanda, Beerman Isabel, Groarke Emma M, Patel Bhavisha A, Spitofsky Nina, Dillon Laura W, Raffo Diego Quinones, Hourigan Christopher S, Kajigaya Sachiko, Ferrucci Luigi, Young Neal |
[Predisposition and progression of myelodysplastic syndromes]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 5 62 (4): 278-288. Makishima Hide |
Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 2021 Feb . Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes. Blood advances 2021 2 5 (4): 1017-1028. Hunter Anthony M, Komrokji Rami S, Yun Seongseok, Al Ali Najla, Chan Onyee, Song Jinming, Hussaini Mohammad, Talati Chetasi, Sweet Kendra L, Lancet Jeffrey E, Padron Eric, List Alan F, Sallman David |
[Characteristics and Clinical Significance of Gene Mutation in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2021 12 29 (6): 1864-1868. Zhao Fang, Wang Kai-Li, Qin Yu-Ting, Nilupar Tuerxun, Patiguli Abulizi, Jiang Ming, Hao Jian-Pi |
Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series. Frontiers in immunology 2021 10 12 715053. Martin de Frémont Grégoire, Hirsch Pierre, Gimenez de Mestral Santiago, Moguelet Philippe, Ditchi Yoan, Emile Jean-François, Senet Patricia, Georgin-Lavialle Sophie, Hanslik Thomas, Maurier François, Adedjouma Amir, Abisror Noémie, Mahevas Thibault, Malard Florent, Adès Lionel, Fenaux Pierre, Fain Olivier, Chasset François, Mekinian Arsè |
ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. International journal of hematology 2022 7 116 (5): 659-668. Morita Yasuyoshi, Nannya Yasuhito, Ichikawa Motoshi, Hanamoto Hitoshi, Shibayama Hirohiko, Maeda Yoshinobu, Hata Tomoko, Miyamoto Toshihiro, Kawabata Hiroshi, Takeuchi Kazuto, Tanaka Hiroko, Kishimoto Junji, Miyano Satoru, Matsumura Itaru, Ogawa Seishi, Akashi Koichi, Kanakura Yuzuru, Mitani Kinu |
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes. Hematological oncology 2022 11 . Lee Wan-Hsuan, Lin Chien-Chin, Wang Yu-Hung, Yao Chi-Yuan, Kuo Yuan-Yeh, Tseng Mei-Hsuan, Peng Yen-Ling, Hsu Cheng-An, Sun Hsun-I, Chuang Yi-Kuang, Hsu Chia-Lang, Tien Feng-Ming, Tsai Cheng-Hong, Chou Wen-Chien, Hou Hsin-An, Tien Hwei-Fa |
IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons???60 years with myelodysplastic syndromes. Experimental hematology & oncology 2022 Oct 11 (1): 73. Wu Junying, Zhang Yudi, Qin Tiejun, Xu Zefeng, Qu Shiqiang, Pan Lijuan, Li Bing, Jia Yujiao, Li Chengwen, Wang Huijun, Gao Qingyan, Cai Wenyu, Gong Jingye, Zhao Songyang, Li Fuhui, Gale Robert Peter, Xiao Zhiji |
Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. American journal of hematology 2022 1 97 (3): 352-372. Patnaik Mrinal M, Tefferi Ayal |
Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. Journal of cancer research and clinical oncology 2022 1 148 (4): 845-856. Jiang Lingxu, Ye Li, Ma Liya, Ren Yanling, Zhou Xinping, Mei Chen, Xu Gaixiang, Yang Haiyang, Lu Chenxi, Luo Yingwan, Zhu Shuanghong, Wang Lu, Shen Chuying, Yang Wenli, Zhang Qi, Wang Yuxia, Lang Wei, Han Yueyuan, Jin Jie, Tong Hongy |
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile. Annals of hematology 2023 8 . Luca Guarnera, Emiliano Fabiani, Cristina Attrotto, Hajro Hajrullaj, Antonio Cristiano, Roberto Latagliata, Susanna Fenu, Francesco Buccisano, Maria Irno-Consalvo, Consuelo Conti, Maria Teresa Voso, Luca Mauril |
Clinical implications of myeloid malignancy?related somatic mutations in aplastic anemia. Clinical and experimental medicine 2023 4 . Lingling Liu, Danfeng Zhang, Qiuhao Fu, Jingdi Wang, Jifeng Yu, Dandan Chen, Fang Wang, Rong Guo, Xinsheng Xie, Zhongxing Jiang, Yingmei |
Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes. Hematology (Amsterdam, Netherlands) 2023 2 28 (1): 2180704. Papadopoulou Vasiliki, Schoumans Jacqueline, Basset Valentin, Solly Françoise, Pasquier Jérôme, Blum Sabine, Spertini Olivi |
[Risk factors for leukemia transformation in patients with myelodysplastic syndromes]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 1 43 (10): 818-825. Zhao S Y, Xu Z F, Qin T J, Qu S Q, Li C W, Jia Y J, Pan L J, Li B, Gao Q Y, Jiao M, Huang H J, Xiao Z |
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes. Blood 2024 4 . Maria Sirenko, Elsa Bernard, Maria Creignou, Dylan Domenico, Andrea Farina, Juan Esteban Arango Ossa, Olivier Kosmider, Robert P Hasserjian, Martin Jädersten, Ulrich Germing, Guillermo F Sanz, Arjan A van de Loosdrecht, Carmelo Gurnari, Matilde Y Follo, Felicitas R Thol, Lurdes Zamora, Ronald Feitosa Pinheiro, Andrea Pellagatti, Harold Kunal Elias, Detlef Thomas Haase, Birgitta Sander, Elisa Orna, Katharina Zoldan, Lea Naomi Eder, Wolfgang R Sperr, Renate Thalhammer, Christina Ganster, Lionel Adès, Magnus Tobiasson, Laura Palomo, Matteo Giovanni Della Porta, Kety H Huberman, Pierre Fenaux, Monika Belickova, Michael R Savona, Virginia Klimek, Fabio P S Santos, Jacqueline Boultwood, Ioannis Kotsianidis, Valeria Santini, Francesc Sole, Uwe Platzbecker, Michael Heuser, Peter Valent, Carlo Finelli, Maria Teresa Voso, Lee Yung Shih, Seishi Ogawa, Michaela Fontenay, Joop H Jansen, José Cervera, Benjamin L Ebert, Rafael Bejar, Peter L Greenberg, Norbert Gattermann, Luca Malcovati, Mario Cazzola, David B Beck, Eva S Hellstrom-Lindberg, Elli Papaemmanu |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: